At the time of writing, Tango Therapeutics Inc [TNGX] stock is trading at $9.61, up 4.12%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TNGX shares have gain 15.23% over the last week, with a monthly amount glided 34.22%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on February 12, 2024, and set its price target to $18. On December 08, 2023, B. Riley Securities initiated with a Buy rating and assigned a price target of $16 on the stock. H.C. Wainwright upgraded its rating to a Buy but stick to its price target of $10 on October 20, 2022. SVB Leerink initiated its recommendation with a Outperform and recommended $25 as its price target on September 20, 2021.
For the past year, the stock price of Tango Therapeutics Inc fluctuated between $2.88 and $13.03. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $9.61 at the most recent close of the market. An investor can expect a potential return of 35.28% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
According to Tango Therapeutics Inc [NASDAQ:TNGX], the company’s sales were 37.23M for trailing twelve months, which represents an 12.23% jump. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -3.39%, Pretax Profit Margin comes in at -2.99%, and Net Profit Margin reading is -3.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.44 and Total Capital is -0.35. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.33 points at the first support level, and at 9.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.85, and for the 2nd resistance point, it is at 10.09.
Ratios To Look Out For
It is important to note that Tango Therapeutics Inc [NASDAQ:TNGX] has a current ratio of 8.23. As well, the Quick Ratio is 8.23, while the Cash Ratio is 1.43. Considering the valuation of this stock, the price to sales ratio is 27.58, the price to book ratio is 3.88.
Transactions by insiders
Recent insider trading involved MVA Investors, LLC, that happened on Jul 02 ’24 when 95000.0 shares were sold., MVA Investors, LLC completed a deal on Jul 01 ’24 to sell 0.11 million shares. Meanwhile, MVA Investors, LLC sold 29000.0 shares on Jun 28 ’24.
